• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

更安全的无菌调配:洁净室用消毒剂的选择和使用。

Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom.

机构信息

Clinical IQ, LLC, Florham Park, New Jersey.

CriticalPoint, LLC, Florham Park, New Jersey.

出版信息

Int J Pharm Compd. 2024 Sep-Oct;28(5):383-393.

PMID:39405576
Abstract

Compounders worldwide are responsible for ensuring that the sterile preparations they dispense are pure, potent, and safe. To achieve that result, proper cleaning and disinfection of International Organization for Standardization controlled environments must occur. Because those tasks must be performed according to established standards, the compounding pharmacist must research regulatory requirements and appropriate products for use. In this report, we focus on U.S. regulations, guiding entities, and effective products that enable compliance with the increasingly stringent procedures required for pharmaceutical compounding. We also review cleaning and disinfecting processes, discuss the importance of correctly choosing and using disinfectants and/ or sporicidal disinfectants with surface claims in the cleanroom, and provide answers to questions frequently asked by staff who use those agents. In addition, we profile specific disinfectants that are compliant with United States Pharmacopeia Chapter <797> and current good manufacturing practice standards. Biological safety cabinets and compounding aseptic containment isolators must undergo an additional process that deactivates hazardous drug residues and removes them from the interior surfaces of those devices before they are cleaned and disinfected, but that discussion is beyond the scope of this article.

摘要

全球的药剂师负责确保他们配制的无菌制剂是纯净、有效且安全的。为了实现这一目标,必须对经过国际标准化组织控制的环境进行适当的清洁和消毒。由于这些任务必须按照既定标准执行,因此药剂师必须研究监管要求和适当的产品。在本报告中,我们重点介绍美国的法规、指导实体和有效产品,这些法规、指导实体和有效产品使药剂师能够遵守药物配制所需的日益严格的程序。我们还回顾了清洁和消毒过程,讨论了在洁净室中正确选择和使用消毒剂和/或具有表面声称的杀孢子消毒剂的重要性,并为使用这些制剂的员工经常提出的问题提供了答案。此外,我们还介绍了符合美国药典第<797>章和现行良好生产规范标准的特定消毒剂。生物安全柜和无菌配制隔离器必须进行额外的处理,以在清洁和消毒之前使危险药物残留物失活并将其从设备内部表面去除,但这一讨论超出了本文的范围。

相似文献

1
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom.更安全的无菌调配:洁净室用消毒剂的选择和使用。
Int J Pharm Compd. 2024 Sep-Oct;28(5):383-393.
2
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom.更安全的无菌调配:洁净室用消毒剂的选择和使用。
Int J Pharm Compd. 2024 Jan-Feb;28(1):44-55.
3
SAFER STERILE COMPOUNDING: Choosing and Using Disinfectants for the Cleanroom.更安全的无菌配制:洁净室消毒剂的选择与使用
Int J Pharm Compd. 2015 Jul-Aug;19(4):268-78.
4
Microbiologic Testing for 503A Sterile-Compounding Pharmacies.503A无菌配制药房的微生物检测
Int J Pharm Compd. 2017 May-Jun;21(3):193-203.
5
Implementing United States Pharmacopeia Chapter <1163>: Quality assurance in pharmaceutical compounding, part 4: cleaning and packaging.实施美国药典第<1163>章:药物配制中的质量保证,第4部分:清洁与包装。
Int J Pharm Compd. 2012 Sep-Oct;16(5):405-14.
6
Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.两种工作实践改变对药房配制无菌制剂微生物污染率的影响。
Am J Health Syst Pharm. 2007 Apr 15;64(8):837-41. doi: 10.2146/060199.
7
Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities.用于药物配制设施的干热去热原烘箱
Int J Pharm Compd. 2015 May-Jun;19(3):182-92.
8
Is Transducer Hygiene sufficient when Vaginal Probes are used in the Clinical Routine?在临床常规操作中使用阴道探头时,换能器卫生是否足够?
Ultraschall Med. 2016 Apr;37(2):137-9. doi: 10.1055/s-0042-103605. Epub 2016 Apr 8.
9
A compounding compliance team at an academic medical center.一个学术医疗中心的调配合规团队。
Am J Health Syst Pharm. 2020 May 19;77(11):882-891. doi: 10.1093/ajhp/zxaa063.
10
Barrier isolators as an alternative to a cleanroom.
Am J Health Syst Pharm. 1999 Jul 15;56(14):1433-6. doi: 10.1093/ajhp/56.14.1433.